Abstract
Exposure of the fetus to the intrauterine milieu can have profound effects on the health of the offspring in adulthood. These observations are highly reproducible in many populations worldwide although the mechanisms behind them remain elusive.
The ‘thrifty phenotype’ hypothesis proposes that poor fetal nutrition leads to programming of metabolism and an adult phenotype that is adapted to poor but not plentiful nutrition. Results of a series of studies demonstrate the powerful influence of the mother’s metabolic state on whether the emerging adult develops obesity and hyperinsulinemia. Importantly, these attributes can be passed on to the next generation non-genetically and can be reversed and prevented.
Such hypothesis has been expanded on by the “Developmental Origins of Health and Disease” (DOHaD) hypothesis which describes the origin of adult disease in terms of fetal developmental ‘plasticity’ or the ability of the fetus to respond to poor in-utero conditions. A wealth of epidemiological evidence has provided a convincing link between a sub-optimal gestational environment and an increased propensity to develop adult onset metabolic disease.
In this paper the factors that participate in the programming of the fetus and infants that lead to endocrine dysfunction in postnatal life are reviewed.
Keywords: Thrifty phenotype hypothesis, Developmental Origins of Health and Disease hypothesis, Type 2 diabetes, Childhood growth, Programming
Current Diabetes Reviews
Title:Environmental and Genetical Aspects of the Link Between Pregnancy, Birth Size, and Type 2 Diabetes
Volume: 8 Issue: 3
Author(s): Arianna Vignini, Francesca Raffaelli, Annamaria Cester, Antonio Iannilli, Valentino Cherubini, Laura Mazzanti and Laura Nanetti
Affiliation:
Keywords: Thrifty phenotype hypothesis, Developmental Origins of Health and Disease hypothesis, Type 2 diabetes, Childhood growth, Programming
Abstract: Exposure of the fetus to the intrauterine milieu can have profound effects on the health of the offspring in adulthood. These observations are highly reproducible in many populations worldwide although the mechanisms behind them remain elusive.
The ‘thrifty phenotype’ hypothesis proposes that poor fetal nutrition leads to programming of metabolism and an adult phenotype that is adapted to poor but not plentiful nutrition. Results of a series of studies demonstrate the powerful influence of the mother’s metabolic state on whether the emerging adult develops obesity and hyperinsulinemia. Importantly, these attributes can be passed on to the next generation non-genetically and can be reversed and prevented.
Such hypothesis has been expanded on by the “Developmental Origins of Health and Disease” (DOHaD) hypothesis which describes the origin of adult disease in terms of fetal developmental ‘plasticity’ or the ability of the fetus to respond to poor in-utero conditions. A wealth of epidemiological evidence has provided a convincing link between a sub-optimal gestational environment and an increased propensity to develop adult onset metabolic disease.
In this paper the factors that participate in the programming of the fetus and infants that lead to endocrine dysfunction in postnatal life are reviewed.
Export Options
About this article
Cite this article as:
Vignini Arianna, Raffaelli Francesca, Cester Annamaria, Iannilli Antonio, Cherubini Valentino, Mazzanti Laura and Nanetti Laura, Environmental and Genetical Aspects of the Link Between Pregnancy, Birth Size, and Type 2 Diabetes, Current Diabetes Reviews 2012; 8 (3) . https://dx.doi.org/10.2174/157339912800563954
DOI https://dx.doi.org/10.2174/157339912800563954 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Application of lncRNAs in Cancer Treatment and Diagnosis
Recent Patents on Anti-Cancer Drug Discovery Strategies Targeting Soluble β-Amyloid Oligomers and their Application to Early Diagnosis of Alzheimer’s Disease
Current Alzheimer Research A New Alzheimers Disease Interventive Strategy: GLP-1
Current Drug Targets Population-based Study of Risk Polymorphisms Associated with Vascular Disorders and Dementia
Current Genomics Regulation of Iron Absorption in Hemoglobinopathies
Current Molecular Medicine From Preclinical to Clinical Trials: An Update on Potential Therapies for Huntington’s Disease
Current Psychopharmacology Spin Trapping: An Essential Tool for the Study of Diseases Caused by Oxidative Stress
Current Topics in Medicinal Chemistry Peptide Immunotherapies in Type 1 Diabetes: Lessons from Animal Models
Current Medicinal Chemistry Effectiveness of the Treatment with Botulinum Toxin Type A (BTX-A) in the Management of the Spasticity in Patients with Amyotrophic Lateral Sclerosis (ALS)
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) Mechanisms of Inflammatory Atherosclerosis in Rheumatoid Arthritis
Current Immunology Reviews (Discontinued) Pathogenesis of Alzheimer Disease: Role of Oxidative Stress, Amyloid-β Peptides, Systemic Ammonia and Erythrocyte Energy Metabolism
CNS & Neurological Disorders - Drug Targets Is Bilirubin a Marker of Vascular Disease and/or Cancer and is it a Potential Therapeutic Target?
Current Pharmaceutical Design Biomedical Consequences of Alcohol Use Disorders in the HIV-Infected Host
Current HIV Research Cardiovascular Effects of Metabolic Surgery on Type 2 Diabetes
Current Cardiology Reviews Obesity and Cancer: Biological Links and Treatment Implications
Current Cancer Drug Targets Role of Oxidative Stress in the Genesis of Atherosclerosis and Diabetes Mellitus: A Personal Look Back on 50 Years of Research
Current Aging Science Editorial [Hot Topic: Recent Developments and Future Directions in the Treatment of Systemic Rheumatic Diseases (Guest Editor: Minoru Satoh) ]
Endocrine, Metabolic & Immune Disorders - Drug Targets The Adenosine A2b Receptor: Its Role in Inflammation
Endocrine, Metabolic & Immune Disorders - Drug Targets Breath Analysis Using SIFT-MS to Assess Metabolic Status in Patients After Gastro-oesophageal Cancer Surgery- a Pilot Study
Current Analytical Chemistry Pediatric Obesity Epidemic: Problem and Solutions
Current Pharmaceutical Design